OxytocinLate decelerations following in-utero exposure

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2003卷 / 1期

关键词：

D O I：

10.1007/s40278-024-56502-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：671 / 671

相关论文

共 50 条

[21] DexamethasoneLack of efficacy following in-utero exposure: case report
Reactions Weekly, 2024, 2035 (1) : 171 - 171
[22] TerbutalineVentricular tachycardia following in-utero exposure: case report
Reactions Weekly, 2020, 1808 (1) : 287 - 287
[23] LidocaineDrug toxicity following in-utero exposure: case report
Reactions Weekly, 2023, 1939 (1) : 274 - 274
[24] DoxorubicinHeart failure following in-utero exposure: case report
Reactions Weekly, 2019, 1743 (1) : 80 - 80
[25] DoxycyclineMicrodeletion syndrome following in-utero exposure: case report
Reactions Weekly, 2023, 1969 (1) : 157 - 157
[26] AntineoplasticsTeratogenicity following in-utero exposure: 4 case reports
Reactions Weekly, 2017, 1672 (1) : 39 - 39
[27] AntineoplasticsVarious toxicities following in-utero exposure: case report
Reactions Weekly, 2021, 1865 (1) : 64 - 64
[28] OxymetazolineCongenital abnormalities following in-utero exposure: case report
Reactions Weekly, 2017, 1657 (1) : 325 - 325
[29] PaclitaxelGrowth failure following in-utero exposure: case report
Reactions Weekly, 2021, 1836 (1) : 625 - 625
[30] RadotinibCongenital malformations following in-utero exposure: case report
Reactions Weekly, 2017, 1634 (1) : 229 - 229

← 1 2 3 4 5 →